1. Malaysia Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Supermax Corporation Berhad

Supermax Corporation Berhad

7106.KL
Supermax Corporation BerhadMY flagMalaysian Stock Exchange
0.27
MYR
- -
- -
810.17MMarket Cap
Supermax Corporation Berhad
7106.KL
(Malaysian Stock Exchange)

Recent

price

0.27

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.29
0.29
0.29
0.3
0.29
0.3
- -
0.33
0.39
0.46
0.64
2.21
0.85
0.26
0.21
0.25
0.22
Revenue per Share
0.05
0.03
0.03
0.03
0.03
0.04
- -
0.02
0.03
0.04
0.16
1.18
0.23
-0.04
-0.06
-0.05
-0.1
Basic EPS, GAAP
- -
0.01
0.03
0.01
-0.01
-0.01
- -
- -
0.03
0.04
0.34
0.98
-0.03
-0.22
-0.25
-0.12
-0.06
Free Cash Flow per Basic Share
0.01
0.01
- -
0.01
0.01
0.01
- -
0.01
0.02
0.01
- -
0.14
0.21
0.04
0.03
- -
- -
Dividend per Share
0.18
0.2
0.25
0.27
0.29
0.32
- -
0.33
0.35
0.38
0.54
1.56
1.57
1.48
1.46
1.42
0.11
Book Value per Share
0.19
0.21
0.23
0.25
0.26
0.29
- -
0.3
0.29
0.33
0.46
1.51
1.59
1.48
1.43
1.33
1.22
Tangible Book Value per Share
3,411
3,502
3,497
3,496
3,496
3,502
1,348
3,450
3,384
3,323
3,313
3,245
3,173
3,164
3,118
3,083
3,083
Basic Weighted Avg Shares
977
1,021
997
1,048
1,004
1,053
- -
1,127
1,304
1,538
2,132
7,164
2,687
821
646
782
675
Sales/Revenue/Turnover
15.91
8.79
12.3
13.26
12.61
13.93
- -
9.56
13.02
12.13
32.46
70
42.43
-17.28
-37.38
-32.15
-52.25
Operating Margin (%)
26
24
24
27
28
- -
- -
41
42
45
62
69
74
85
68
- -
- -
Depreciation Expense
159
104
122
120
96
127
- -
67
107
123
525
3,817
719
-141
-176
-160
-301
Net Income, GAAP
13.53
7.21
11.58
19.69
25.8
17.07
- -
34.88
31.97
28.6
21.38
21.71
28.54
- -
- -
- -
- -
Effective Tax Rate (%)
16.26
10.2
12.2
11.42
9.52
12.06
- -
5.96
8.18
8
24.62
53.27
26.75
-17.16
-27.18
-20.51
-44.66
Profit Margin (%)
225
263
278
275
214
154
- -
68
6
34
407
3,285
3,180
2,259
1,613
1,008
655
Working Capital
141
140
115
127
146
99
- -
107
62
61
102
64
53
19
22
14
17
LT Debt
692
769
834
898
944
1,036
- -
1,070
1,023
1,134
1,551
4,894
5,032
4,692
4,467
4,093
3,770
Total Equity
14.47
7.97
9.79
9.52
7.43
8.77
- -
9.17
7.72
8.76
30.2
96.16
13.94
- -
- -
- -
- -
Return on Invested Capital (%)
25.51
11.98
11.9
10.42
7.75
9.22
- -
8.99
7.02
8.32
27.82
97.73
12.63
- -
- -
- -
- -
Return on Capital (%)
42.4
15.93
15.49
13.09
9.74
12
- -
11.87
9.22
10.05
34.49
111.56
14.31
-2.92
-3.81
-3.59
-12.58
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
147
144
146
LT Borrowings
18
17
17
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,057
3,057
3,057
Market Capitalization
1,386
1,033
940

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,201
1,085
991
Cash, Cash Equivalents & STI
855
757
638
Accounts Receivable, Net
79
72
70
Inventories
166
149
189
Total Current Liabilities
320
320
336
Payables & Accruals
- -
- -
- -
ST Debt
147
144
146
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
39.71%
-8.38%
Free Cash Flow
- -
119.38%
-53.55%
Net Income, GAAP
- -
88.51%
-8.67%
Sales/Revenue/Turnover
- -
20.77%
21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
178
146
143
180
646
2025
225
199
204
155
782
2026
206
187
127
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
- -
-0.05
-0.06
2025
-0.02
- -
-0.01
-0.02
-0.05
2026
-0.04
-0.02
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
- -
- -
- -
0.03
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Merit Medical Systems, Inc. (MMSI)
Hologic, Inc. (HOLX)
Nakanishi Inc. (7716.T)
InnerScope Hearing Technologies, Inc. (INND)
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
Repligen Corporation (RGEN)
Business
Supermax Corporation Berhad operates as an investment holding company with primary focus on the manufacturing, global distribution, and marketing of healthcare and eyecare products from its Malaysian base. The company produces a comprehensive range of medical gloves, including both natural rubber and nitrile latex varieties, alongside specialized personal protective equipment. Furthermore, Supermax has established itself in the eyecare sector, engaging in the manufacturing, distribution, and marketing of contact lenses, a venture initiated in 2014 with its dedicated facility commencing operations in 2016. The group's operational scope extends to the trading, importing, and worldwide distribution of its glove products, supported by energy-efficient biomass systems within its facilities. Supermax also maintains interests in property holding activities through its subsidiaries. As a prominent own-brand manufacturer, Supermax markets its offerings under well-recognized labels such as Supermax, Aurelia, and Maxter, catering to a global clientele of laboratories, hospitals, pharmacists, doctors, and surgeons. With eleven manufacturing facilities in Malaysia and an annual glove production capacity reaching up to 24 billion pieces, the company fulfills approximately 12% of the global demand for latex examination gloves. Its extensive international presence spans over 160 countries across the Americas, Europe, the Middle East, Asia, and the South Pacific, reinforced by eight distribution centers and corporate offices located in key global markets, alongside collaborations with over 1,200 independent distributors. In recent times, the company has faced challenges, including import bans by the United States in October 2021 and contract terminations by Canada in November 2021, both citing allegations of forced labor. Subsequently, Norway's sovereign wealth fund placed Supermax under observation in June 2022 due to similar human rights concerns. In response, Supermax initiated plans for an advanced manufacturing facility in Texas, US, which began production in January 2025, and is investing heavily in automation, robotics, and AI to enhance efficiency and reduce reliance on manual labor. The company, founded in 1987, maintains its headquarters in Sungai Buloh, Malaysia.